Erratum for the Research Article: “RANKL blockade prevents and treats aggressive osteosarcomas” by Y. Chen, M. A. Di Grappa, S. D. Molyneux, T. D. McKee, P. Waterhouse, J. M. Penninger, R. Khokha

See allHide authors and affiliations

Science Translational Medicine  03 Feb 2016:
Vol. 8, Issue 324, pp. 324er2
DOI: 10.1126/scitranslmed.aaf2877

In the manuscript “RANKL blockade prevents and treats aggressive osteosarcomas,” the recombinant RANK-Fc received as a gift from Amgen consisted of the murine extracellular domain of RANK fused to the Fc portion of murine IgG1, not human IgG1 as reported in the paper. The PDF and HTML (full text) have been corrected.

Stay Connected to Science Translational Medicine

Navigate This Article